Financial life in a big town

Covidien plc will spin off its Hazelwood-based drug business, turning it into an independent company that may restore the historic corporate name of Mallinckrodt.

Covidien, based in Dublin, makes medical devices and medical supplies in addition to drugs. The proposed spinoff also will have its legal headquarters in Ireland, largely for tax reasons, company executives said in a conference call.

But the spinoff’s U.S. operation will be based in Hazelwood, and its new CEO will work from here. Spokesman Steve Littlejohn said the company has not made a final decision on its name, “but chances are good that it will be Mallinckrodt.”

Covidien’s pharmaceutical business has $2 billion in sales, with two-thirds of that coming in the U.S. market. It turned an operating profit of $318 million this fiscal year.

The drug business is a large provider of acetaminophen, the ingredient in Tylenol, and the largest U.S. supplier of opioids; both are pain medicines. Other lines include contrast products used with medical imagery and nuclear medicine products.

The pharmaceutical operation currently employs about 2,500 people in metro St. Louis. A company spokesman said the move should have no immediate impact on jobs here. Some jobs might be added as the firm sets up its own administrative operation.

Analysts had speculated that Covidien might get rid of the drug operation. Although profitable, it is less lucrative than the rest of Covidien and demands a higher investment in research and development. The drug operation earns a 16 cent operating profit for every dollar of sales, compared with 28 cents for the rest of the company.

The drug operation has a “lumpy” revenue history, notes analyst Aaron Vaughn of Edward Jones in Des Peres. The division is largely a generic drugmaker, and that sector suffered through a price war in past years, he noted.

“We thought they would be getting the business right-sized so that they could spin it off and let it grow on its own,” he said.

Covidien Chief Executive Jose Almeida said the pharmaceutical drug division’s performance had improved in recent years.

“We’re confident the business can now stand on its own,” he said in a conference call Thursday morning.

He said the company had been thinking about shedding the business for several years, citing “major differences” between drugs and Covidien’s other medical products. The operations have different business models, sales channels, customers and capital requirements, and demand different talents, he said.

Separating the operations would allow both to focus on their own strategies, Almeida said payday loans no teletrack. Shareholders also might get more value over the long term, he said.

The drug business “definitely needs some investment,” said analyst Jeff Jonas of Gabelli & Co. in an interview with Bloomberg News. “They need to find new products, invest in the pipeline. That’s a multiyear process.”

Research and development consumes 7 percent of revenue in the drug division, compared with 4 percent in the rest of Covidien.

The spinoff would be in the form of a stock distribution, tax-free to U.S. shareholders, the company said. That tax-free aspect made the option of a spinoff superior to the alternative of selling the unit, company officials said.

The spinoff could take 18 months to complete and would need approval of regulators.

Bloomberg News, citing unidentified sources, reported last summer that Covidien had tried to sell the unit, but talks broke down.

Almeida said he has picked a CEO for the new company, although he didn’t name the person. The person is a ’strong leader” with “broad pharmaceutical experience,” Almeida said, and will join the spinoff from another company.

The drug operation is now headed by Matt Harbaugh, the drug division’s chief financial officer serving as interim president. Based in Hazelwood, he has led the unit since the previous president left last year.

Besides its Hazelwood headquarters, the drug unit has a research operation in Webster Groves, a nuclear medicine facility in Maryland Heights and a plant just north of downtown St. Louis.

That plant sits on what was the Mallinckrodt family farm. G. Mallinckrodt & Co. was founded there in 1867 and grew up as a chemical and drug firm. It refined uranium for the Manhattan Project, which created the atomic bomb during World War II.

Avon Products acquired Mallinckrodt in 1982. Avon sold the company to International Minerals and Chemical Corp. in 1986, which later changed its own name to Mallinckrodt.

In 2000, Tyco bought the company. After Tyco went bankrupt amid scandals, its health care operations were spun off as Covidien in 2007.

Without the drug business, Covidien would have $9.6 billion in sales. Covidien’s remaining business makes trays, hypodermic needles, retractors, pumps for patient feeding and pain management, and other medical devices.

Covidien stock rose $1.39 to $43.55 on Thursday.

Source

The ousted chief of Olympus, the Japanese camera-maker under investigation for hiding investment losses for years, is confident about making a comeback _ a return he vows will clean up the company’s scandal-tainted management for good.

Michael Woodford, the former President and Chief Executive at Olympus Corp., said Thursday he was lining up investor support and talking to other “influential people in the Japanese establishment” for his return to the company.

Woodford, in town this week for such meetings, declined to give specifics, saying the discussions were “delicate.” But he was clearly upbeat about the prospects, noting he had enough support to call a general shareholders’ meeting _ a key move for managerial change.

“I wouldn’t be doing this. I wouldn’t be putting myself through this enormous physical and emotional effort if I didn’t think it could be successful,” he told The Associated Press, weary but flushed from the bustle of reading email from Olympus employees cheering him on.

“This is uncharted territory. You have the world looking at this story,” he said at a Tokyo hotel.

The deception at Olympus, dating back to the 1990s, to hide 117.7 billion yen ($1.5 billion) in investment losses became known only when Woodford blew the whistle. He questioned exorbitant fees for advice on the acquisition of British medical equipment maker Gyrus Group and other expensive acquisitions in 2008.

Woodford recalled that he thought the Gyrus purchase was unwise and unneeded at the time, but said he never dreamed it involved anything illegal.

Woodford, a 51-year-old Briton and a rare foreigner to lead a major Japanese company, was fired in October after confronting Olympus directors.

Woodford is demanding the resignation of the entire board, including President Shuichi Takayama, who replaced him and initially declared all the spending as legitimate in a news conference.

“It’s offensive to common sense,” said Woodford.

The battle over who will lead the camera and medical equipment maker and its 40,000 employees could come to a head at the next shareholders’ meeting. Takayama said Thursday that might be held in March or April.

Olympus met its deadline to avoid being removed from the Tokyo Stock Exchange by filing corrected earnings for the April-September first half and for the past five fiscal years on Wednesday.

But it is still under a criminal investigation, and could be delisted later on.

Olympus appointed three outsiders to a new reform committee Thursday to beef up governance and present a plan to shareholders. The committee is in addition to an earlier panel announced by Takayama, which is investigating the scandal.

The Olympus fiasco has prompted soul-searching in Japan Inc. on living up to global standards. Ruling and opposition legislators met with Woodford earlier this week to hear his ideas about governance.

The company’s loss of 32.3 billion yen ($414 million) for the first half of the fiscal year, through September, a reversal from a 3.8 billion yen profit the same period a year earlier, was mainly from the economic downturn and losses from Thai flooding, Takayama said.

“Capital adequacy ratio is a big problem, and we are considering how we can overcome it,” Takayama told reporters. “We are considering various options, including a capital tie-up and operational or sales tie-ups.”

Woodford said he was opposed to alliances, which he said would likely compromise Olympus’ independence, and he had better ways to get capital to shore up its hobbled balance sheet.

“Because of the strong cash flows and profitability of the medical business, we could raise funding from additional sources without losing our sovereignty,” he said.

Olympus should focus on core businesses _ medicine, microscopes, industrial products and cameras and other consumer products _ and stop acquiring unrelated companies, such as pet food, plastic plates and cosmetics, he said.

He promised a more transparent Olympus, with more outside board members. He said he was preparing the candidates already.

Olympus stock, which plunged after the scandal hit, has recouped some of the losses but dropped 21 percent to close at 1,041 yen Thursday.

A third-party panel set up by Olympus, including a former Japanese Supreme Court judge, released the findings of an investigation earlier this month, which said top executives who were “rotten to the core” had orchestrated the accounting cover-up spanning three decades.

The fees for financial advice and overvalued acquisitions were part of an elaborate deception utilizing overseas banks and several funds to keep the massive losses off the company’s books, according to Olympus. Japanese magazine Facta was first to report the dubious money.

It is still unclear if Woodford will manage a comeback.

Some people, such as former board member Koji Miyata, see him as a hero and have begun an online campaign to bring back Woodford.

Miyata says Woodford, a 30-year employee at Olympus, was groomed from the start to lead the company.

“There are a lot of senior managers who might be good for the No. 2 post, but someone who is destined to be No. 1 is totally different,” he said in a recent interview with The AP.

“He has principle. He is uncompromising,” he said of Woodford, whom he has known for 25 years. “He isn’t swayed. He doesn’t avoid confrontation. He sticks to his guns that what is wrong is simply wrong.”

Woodford, who sees himself as a “salaryman,” denied it was his nationality that might make him Olympus’ savior.

“I’m sure there are some Japanese people who could do similarly to me,” he said. “I know the company. I’ve worked there. It doesn’t matter if I’m English or Japanese, in that sense.”

Source

Plastics maker Spartech Corp. cut its loss for the fourth quarter in half.

Clayton-based Spartech reported a loss of $27.7 million in the fourth quarter that ended Oct. 29, or 90 cents a share, compared to a loss of $55.7 million, or $1.81 a share a year ago.

Spartech produces plastic sheet, compounds and packaging products. Sales of higher margin products for transportation and construction customers helped Spartech’s sales increase 13 percent in the quarter, to $293.2 million, compared with $259.6 million a year ago.

For its 2011 fiscal year, Spartech posted a loss of $21.1 million, compared with a loss of $50.4 million in fiscal 2010.   

Source

Americans’ confidence in the economy in November bounced back to its highest level since July, the latest sign that they are beginning to feel more cheerful about spending during the holiday shopping season.

The Conference Board, a private research firm, says Tuesday that its Consumer Confidence Index rose 15 points to 56.0. That’s up from a revised 40.9 in October _ the lowest level since the recession _ and the biggest jump since the 59.2 reading in July. The November number is encouraging, but far below the reading of 90, which indicates an economy on solid footing.

The confidence numbers are widely watched by economists because consumer spending accounts for 70 percent of economic activity. The confidence of U.S. consumers slipped after the summer amid renewed fears about a second recession. But Americans, who have been grappling with high unemployment and a weak housing market, have shown that they are feeling much more comfortable spending. Over the past weekend, for instance, they spent more than they ever have before during Black Friday weekend, the traditional start of the holiday shopping season.

“Consumers appear to be entering the holiday season in better spirits, though overall readings remain historically weak,” said Lynn Franco, director of The Conference Board Consumer Research Center in a statement low fee cash advance.

Franco noted that consumers’ assessment of current conditions improved after six months of steady declines. Consumers’ anxiety regarding the short-term outlook for business conditions, jobs and income prospects eased considerably.

One barometer of the index, which measures how shoppers feel now, rose to 38.3 from 27.1. The other gauge, which measures how shoppers say they will feel over the next six months, rose to 67.8 from 50.0.

Consumers have several reasons to be more confident as there have been some signs of improvement in the economy. Earlier this month, for instance, the Labor Department reported that the job market improved modestly as unemployment rate nudged down to 9 percent in October from 9.1 percent in September. The month marked the 13th consecutive month of job gains.

Source

Whether people celebrate or criticize Occupy Wall Street, the movement has reinvigorated calls for local buying just in time for the manic holiday shopping season.

Buying local and American-made became a battle cry for some in the movement that blames big business greed for shuttering American operations and shipping those jobs overseas.

“Some people talk about buying local and not supporting large chain stores, but really I think we want to encourage people to think consciously about where they shop,” said Zach Chasnoff, 33, of south St. Louis.

Chasnoff has wielded a bullhorn at a few Occupy St. Louis rallies, though he said he couldn’t speak as a representative of a movement. He said he’d been waiting for an opportunity to ignite this particular discussion.

Chasnoff owns a house painting business that fluctuates from two to seven employees during his busy season. When the bottom fell out of the economy in 2008, he was virtually unemployed for about seven months and didn’t know if he’d keep his house, he said. Meanwhile, bank bailouts and news of continued executive bonuses infuriated him. He blames greed for companies’ transferring jobs overseas and cheap foreign goods for undercutting American-made items.

Many economists challenge that logic, saying that free trade ultimately benefits the U payday loans.S.

“It feels almost anti-patriotic to buy goods made elsewhere right now. You are perpetuating the loss of manufacturing jobs,” Chasnoff said, echoing long-standing protests by some against, for instance, buying foreign cars.

Buying local, on the other hand, puts consumers, not corporations, in control, he said.

Would it work?

Steve Farazzi, a professor of economics at Washington University, said that the wage disparity concerns at the root of the Occupy Wall Street movement wouldn’t be solved by shopping at boutiques and farmers markets.

“I’d have a hard time telling people that their holiday shopping patterns will have an important impact on income distribution,” Farazzi said.

If globalization has killed American jobs and driven down wages, then the tool to combat the trend would be higher wages in emerging markets such as China, not necessarily closing operations there. China’s extremely cheap labor is the problem for American workers, not the fact that Chinese workers have jobs formerly held by Americans, Farazzi explained.

Rising global wages would level the playing field for American workers, he said, and it would increase the demand for all goods if we have more people who can afford to buy. But Farazzi acknowledged that a push to boost wages for Chinese workers

Is this the end of the app as we know it? The app is dead. Long live the web app?

It may be too early to pronounce the downloadable application officially dead, but some tech pundits are already preparing obituaries for this staple of the mobile world.

The number of people applying for unemployment benefits fell last week to the lowest level since early April, a sign that layoffs are easing and hiring may pick up.

The Labor Department says weekly applications dropped by 5,000 to a seasonally adjusted 388,000. It was the fourth decline in five weeks.

The four-week average, a less volatile measure, dropped to 396,750. That’s the first time the average been below 400,000 in seven months.

Applications need to consistently drop below 375,000 to signal sustained job gains payday loan lenders. They haven’t been that low since February.

The total number of people receiving benefits also fell to the lowest level since Sept. 2008, when Lehman Brothers collapsed and the financial crisis intensified.

Source

Umberto Bossi, the longtime ally of former Italian premier Silvio Berlusconi, says his Northern League party won’t back any government led by economist Mario Monti “for now.”

Bossi says he told Italy’s president that his party will be a “vigilant” opposition to any Monti government until the economist spells out his program to rescue Italy’s troubled economy.

Berlusconi resigned Saturday after Italy came under enormous pressure for its sovereign debt.

Bossi says “for now, we said no online pay day loans.” He adds when Monti reveals his policies, the League will decide on a measure-by-measure basis.

Italy’s president could ask Monti to try to form a government to rescue Italy from looming financial disaster after talks with all parties Sunday.

Source

BERLIN

ROME